All articles from EyeWorld.org on the topic of cataract surgery. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
➤ Prospective trial reveals impact of home OCT in wet AMD management ➤ Devices receive FDA 510(k) clearance ➤ Review date set for BLA for treatment of macular telangiectasia type 2 ➤ FDA grants IND to gene therapy for patients with geographic atrophy ➤ Acquisition news ➤ ASCRS news and events
The choice between using bimanual or coaxial I/A depends on a number of factors, including physician preference and the type of case. Two surgeons discussed what they use and what may be beneficial in certain cases.
The Scheie Eye Institute residents reviewed “Visual outcome and postoperative complications of cataract surgery in patients with ocular surface disorders” from the Journal of Cataract & Refractive Surgery.
Since its approval, femtosecond laser-assisted cataract surgery (FLACS) has divided cataract surgeons into frequent users of the technology and those who do not think that it brings value to their practice. EyeWorld spoke with two surgeons who say they consistently benefit from FLACS in their practice.
Cataract Editor Mitchell Weikert, MD, shared highlights of the ASCRS Annual Meeting for him and gave a sneak peek into the articles in the section.
➤ Topline results from trial for biologic eye drop for dry eye ➤ First patient dosed in Phase 3 trial evaluating oral non-opioid sedation ➤ First patient dosed in retinitis pigmentosa gene therapy trial ➤ Clinical program for IOP-lowering drug discontinued ➤ ASCRS news and events
➤ 52-week Phase 3 data published for cyclosporine, 0.1% ➤ First patient enrolled in Phase 3 trial assessing new treatment for MGD ➤ Geographic atrophy treatment trial advances to highest dose ➤ New dataset added to support various areas of research and development ➤ ASCRS news and events
➤ Twelve-month results for Phase 2 trial evaluating heat-therapy system for MGD ➤ Topline results from targeted photobiomodulation for treatment of progressive myopia ➤ Enrollment complete in Phase 3 trials to evaluate new wet AMD therapy ➤ ‘Low tech’ way to prioritize cataract surgery ➤ ASCRS news and events
While there a lot of different technologies that can give patients excellent refractive results after cataract surgery, this area keeps expanding and improving. As more options become available, it increases the complexity of talking to patients. This is what the symposium Having “The Talk” focused on at the 2024 ASCRS Annual Meeting.
➤ CRISPR gene-editing trial shows ‘exciting potential’ ➤ Study: laser vision correction clinics missing opportunities ➤ Broad-based protection observed with investigational geographic atrophy therapy ➤ FDA accepts IND for diabetic macular edema therapy ➤ Phase 2 trial for non-proliferative diabetic retinopathy therapy does not meet primary endpoint ➤ ASCRS news and events